PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 13,270 Value ($000) $1,159 Avg Close $81.85 Range $62.24 - $96.54
Q2 2024
Shares 82,791 Value ($000) $2,869 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 93,186 Value ($000) $2,696 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 107,542 Value ($000) $2,466 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 139,494 Value ($000) $2,327 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 163,425 Value ($000) $4,514 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 122,024 Value ($000) $2,807 Avg Close $16.79 Range $10.62 - $25.69
Q4 2022
Shares 194,704 Value ($000) $2,124 Avg Close $8.44 Range $7.24 - $11.46
Q3 2022
Shares 191,193 Value ($000) $1,612 Avg Close $9.46 Range $7.68 - $11.97
Q2 2020
Shares 28,598 Value ($000) $505 Avg Close $12.55 Range $6.00 - $19.67